ATE288265T1 - Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen - Google Patents
Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuenInfo
- Publication number
- ATE288265T1 ATE288265T1 AT98929625T AT98929625T ATE288265T1 AT E288265 T1 ATE288265 T1 AT E288265T1 AT 98929625 T AT98929625 T AT 98929625T AT 98929625 T AT98929625 T AT 98929625T AT E288265 T1 ATE288265 T1 AT E288265T1
- Authority
- AT
- Austria
- Prior art keywords
- mood disorders
- composition
- healthy individuals
- relieving mood
- relieving
- Prior art date
Links
- 208000019022 Mood disease Diseases 0.000 title abstract 2
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Percussion Or Vibration Massage (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000365A IT1291930B1 (it) | 1997-06-18 | 1997-06-18 | Composizione riequilibratrice delle turbe dell'umore in individui sani |
| PCT/IT1998/000157 WO1998057629A1 (en) | 1997-06-18 | 1998-06-12 | Composition for controlling mood disorders in healthy individuals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE288265T1 true ATE288265T1 (de) | 2005-02-15 |
Family
ID=11405131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98929625T ATE288265T1 (de) | 1997-06-18 | 1998-06-12 | Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6335021B1 (de) |
| EP (1) | EP1001760B1 (de) |
| JP (1) | JP2002505681A (de) |
| KR (1) | KR20010013887A (de) |
| AT (1) | ATE288265T1 (de) |
| AU (1) | AU7930498A (de) |
| CA (1) | CA2294589A1 (de) |
| DE (1) | DE69828881T2 (de) |
| DK (1) | DK1001760T3 (de) |
| ES (1) | ES2236910T3 (de) |
| IT (1) | IT1291930B1 (de) |
| PT (1) | PT1001760E (de) |
| WO (1) | WO1998057629A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2806307B1 (fr) * | 2000-03-20 | 2002-11-15 | Mane Fils V | Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation |
| WO2002070037A2 (en) * | 2001-03-04 | 2002-09-12 | Sterling Medivations, Inc. | Infusion hub assembly and fluid line disconnect system |
| HUP0400007A2 (hu) * | 2001-05-29 | 2004-04-28 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Alkanoil-L-karnitin alkalmazása anhedónia kezelésére szolgáló gyógyászati készítmény előállítására |
| US7700074B2 (en) * | 2002-02-07 | 2010-04-20 | Pettegrew Jay W | Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism |
| US7407778B2 (en) * | 2002-02-07 | 2008-08-05 | Pettegrew Jay W | Compounds, compositions and methods for treating neuropsychiatric disorders |
| US20050272812A1 (en) * | 2002-02-07 | 2005-12-08 | Pettegrew Jay W | Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans |
| US20040071681A1 (en) * | 2002-10-10 | 2004-04-15 | Lydia Muller | Method and composition for reducing cravings for a craved substance |
| US20060257842A1 (en) * | 2003-05-29 | 2006-11-16 | Pettegrew Jay W | Cryopreservation media and molecules |
| ATE437884T1 (de) * | 2003-05-29 | 2009-08-15 | Jay W Pettegrew | Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen |
| US8173618B2 (en) * | 2003-07-25 | 2012-05-08 | University Of Massachusetts | Formulations for reducing neuronal degeneration |
| JP2006137746A (ja) * | 2004-10-13 | 2006-06-01 | Otsuka Pharmaceut Factory Inc | オレキシン誘導組成物 |
| WO2007011839A2 (en) * | 2005-07-15 | 2007-01-25 | Agilis Systems, Inc. | Mobile resource location-based customer contact systems and methods |
| US20070289258A1 (en) * | 2006-06-14 | 2007-12-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Individualized pharmaceutical selection and packaging |
| US20080052114A1 (en) * | 2005-11-30 | 2008-02-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods related to nutraceuticals |
| US20070136092A1 (en) * | 2005-11-30 | 2007-06-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging |
| US20110145009A1 (en) * | 2005-11-30 | 2011-06-16 | Jung Edward K Y | Methods and systems related to transmission of nutraceutical associatd information |
| US8068991B2 (en) * | 2005-11-30 | 2011-11-29 | The Invention Science Fund I, Llc | Systems and methods for transmitting pathogen related information and responding |
| US20080004905A1 (en) * | 2006-06-28 | 2008-01-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for analysis of nutraceutical associated components |
| US7827042B2 (en) * | 2005-11-30 | 2010-11-02 | The Invention Science Fund I, Inc | Methods and systems related to transmission of nutraceutical associated information |
| US7927787B2 (en) * | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
| US8340944B2 (en) * | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
| US8297028B2 (en) | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
| US8000981B2 (en) | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
| US20080114577A1 (en) * | 2005-11-30 | 2008-05-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems associated with nutraceutical related assays |
| US20080033763A1 (en) * | 2005-11-30 | 2008-02-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems related to receiving nutraceutical associated information |
| US7974856B2 (en) | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
| US20070124176A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
| US20070124219A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized nutraceutical selection and packaging |
| US10296720B2 (en) * | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
| US8597640B2 (en) * | 2007-10-31 | 2013-12-03 | University Of Massachusetts Lowell | Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
| EP2582368B1 (de) | 2010-06-16 | 2018-05-09 | Alfasigma S.p.A. | Acetyl-L-carnitin zur Erhöhung der Neurogenese in neuronalem Gewebe |
| MX2022012693A (es) | 2020-05-15 | 2022-11-07 | Alfasigma Spa | Composicion que comprende metilfolato. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0340759A1 (de) * | 1988-05-06 | 1989-11-08 | MAGIS FARMACEUTICI S.p.A. | Salze von O-Mono(di)-acetyl-glycero-mono-(bis)-(di)-Phosphaten von L-Acetylcarnitin und von L-Acetylcarnitin-Estern |
| JP3942207B2 (ja) | 1995-02-17 | 2007-07-11 | 武田薬品工業株式会社 | うつ性症状改善剤 |
| US5977162A (en) * | 1996-09-16 | 1999-11-02 | Seidman; Michael D. | Therapeutic treatment for auditory function |
| US6066664A (en) * | 1997-06-06 | 2000-05-23 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Method for decreasing the appetite in bulimic, overweight individuals |
-
1997
- 1997-06-18 IT IT97RM000365A patent/IT1291930B1/it active IP Right Grant
-
1998
- 1998-06-12 US US09/446,358 patent/US6335021B1/en not_active Expired - Fee Related
- 1998-06-12 JP JP50409799A patent/JP2002505681A/ja active Pending
- 1998-06-12 WO PCT/IT1998/000157 patent/WO1998057629A1/en active IP Right Grant
- 1998-06-12 KR KR1019997011909A patent/KR20010013887A/ko not_active Application Discontinuation
- 1998-06-12 ES ES98929625T patent/ES2236910T3/es not_active Expired - Lifetime
- 1998-06-12 DK DK98929625T patent/DK1001760T3/da active
- 1998-06-12 PT PT98929625T patent/PT1001760E/pt unknown
- 1998-06-12 EP EP98929625A patent/EP1001760B1/de not_active Expired - Lifetime
- 1998-06-12 DE DE69828881T patent/DE69828881T2/de not_active Expired - Fee Related
- 1998-06-12 AT AT98929625T patent/ATE288265T1/de not_active IP Right Cessation
- 1998-06-12 AU AU79304/98A patent/AU7930498A/en not_active Abandoned
- 1998-06-12 CA CA002294589A patent/CA2294589A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2236910T3 (es) | 2005-07-16 |
| US6335021B1 (en) | 2002-01-01 |
| IT1291930B1 (it) | 1999-01-21 |
| KR20010013887A (ko) | 2001-02-26 |
| JP2002505681A (ja) | 2002-02-19 |
| PT1001760E (pt) | 2005-04-29 |
| ITRM970365A1 (it) | 1998-12-18 |
| DK1001760T3 (da) | 2005-05-23 |
| EP1001760A1 (de) | 2000-05-24 |
| DE69828881T2 (de) | 2006-01-19 |
| EP1001760B1 (de) | 2005-02-02 |
| ITRM970365A0 (de) | 1997-06-18 |
| WO1998057629A1 (en) | 1998-12-23 |
| DE69828881D1 (de) | 2005-03-10 |
| AU7930498A (en) | 1999-01-04 |
| CA2294589A1 (en) | 1998-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE288265T1 (de) | Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen | |
| NO972972D0 (no) | Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse | |
| DE69612012D1 (de) | Verbundwerkstoff zur verwendung bei der herstellung des shuhwerks | |
| DE69637021D1 (de) | Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der Progression neuropathischer Schmerzerkrankungen | |
| FI970771L (fi) | Uusia allergisten sairauksien hoidossa käyttökelpoisia substituoituja piperidiinejä | |
| DE60133389D1 (de) | Gabapentinanaloga für schlafstörungen | |
| DE69718284D1 (de) | Sprachsynthesesystem und Wellenform-Datenbank mit verringerter Redundanz | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| PT1124556E (pt) | Utilizacao de (r)-tofisopam opticamente puro para tratamento e prevencao de perturbacoes da ansiedade e sua composicao | |
| ID23175A (id) | Penggunaan benzopiranol untuk mengobati gangguan syaraf | |
| DE59709922D1 (de) | Pflaster zur transdermalen anwendung von pergolid | |
| DE69727674D1 (de) | Zur herstellung von gebrannten mustern | |
| DE50010234D1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| NO990450D0 (no) | Behandling av sinnslidelser | |
| NO974569D0 (no) | Benzamider for behandling av neurodegenerative forstyrrelser | |
| ATE229336T1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
| DE59711240D1 (de) | Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge | |
| FI962592A0 (fi) | Uudet välituotteet keinotekoisina makeutusaineina käyttökelpoisten L-aspartyyli-D-alfa-aminoalkanoyyli-(S)-N-alfa-alkyylibentsyyliamidien syntetisoimiseksi | |
| BR9909868A (pt) | Ascorbato de paroxetina | |
| EP0757694A4 (de) | Thioether zur verwendung in der herstellung bifunktioneller chelatisierungsmittel für therapeutische radiopharmazeutika | |
| NO984430D0 (no) | Anvendelse av en inhibitor av Na+/H+-utveksler for fremstilling av medikament for behandling av profylakser av sykdommer i sentralnervesystemet | |
| LV11659A (lv) | Sprotu konservu izgatavosanas panemiens | |
| NO984964D0 (no) | Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og depresjon | |
| ITTV940071A0 (it) | Metodo di insegnamento dell'arte della musica attraverso elementi naturali e colori |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1001760 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |